A detailed history of Quantbot Technologies LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Quantbot Technologies LP holds 111,181 shares of AMRX stock, worth $872,770. This represents 0.04% of its overall portfolio holdings.

Number of Shares
111,181
Previous 29,662 274.83%
Holding current value
$872,770
Previous $188,000 392.02%
% of portfolio
0.04%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.42 - $8.83 $523,351 - $719,812
81,519 Added 274.83%
111,181 $925,000
Q2 2024

Aug 09, 2024

BUY
$5.36 - $7.11 $158,988 - $210,896
29,662 New
29,662 $188,000
Q2 2023

Aug 08, 2023

SELL
$1.33 - $3.1 $14,837 - $34,583
-11,156 Reduced 99.99%
1 $0
Q1 2023

May 12, 2023

SELL
$1.27 - $2.7 $37,081 - $78,834
-29,198 Reduced 72.35%
11,157 $15,000
Q4 2022

Feb 13, 2023

SELL
$1.96 - $2.61 $488 - $649
-249 Reduced 0.61%
40,355 $80,000
Q3 2022

Nov 07, 2022

BUY
$2.02 - $3.62 $71,718 - $128,524
35,504 Added 696.16%
40,604 $82,000
Q2 2022

Aug 09, 2022

BUY
$3.01 - $4.46 $15,350 - $22,746
5,100 New
5,100 $16,000
Q1 2020

May 13, 2020

SELL
$2.46 - $5.35 $140,301 - $305,126
-57,033 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$2.65 - $5.56 $114,676 - $240,603
43,274 Added 314.51%
57,033 $274,000
Q3 2019

Nov 12, 2019

SELL
$2.29 - $7.1 $46,056 - $142,795
-20,112 Reduced 59.38%
13,759 $39,000
Q2 2019

Aug 13, 2019

BUY
$6.44 - $14.29 $218,129 - $484,016
33,871 New
33,871 $242,000
Q1 2019

May 13, 2019

SELL
$11.87 - $14.84 $7,086 - $8,859
-597 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$13.09 - $21.49 $7,814 - $12,829
597 New
597 $8,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.19B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.